Champions Oncology, Inc.
(NASDAQ : CSBR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.81%89.371.3%$810.51m
AMGNAmgen Inc.
1.42%188.141.2%$637.94m
GILDGilead Sciences, Inc.
0.44%65.840.9%$484.42m
BIIBBiogen Inc.
0.84%323.881.3%$431.05m
ILMNIllumina, Inc.
1.30%300.753.5%$315.41m
REGNRegeneron Pharmaceuticals, Inc.
0.66%421.372.6%$292.09m
VRTXVertex Pharmaceuticals Incorporated
0.96%184.821.9%$256.02m
ALXNAlexion Pharmaceuticals, Inc.
0.88%128.672.0%$221.61m
SRPTSarepta Therapeutics, Inc.
1.44%138.5015.4%$154.52m
AAgilent Technologies, Inc.
0.00%77.891.6%$150.81m
EXASExact Sciences Corporation
8.72%90.5525.3%$143.83m
INCYIncyte Corporation
1.12%84.262.5%$113.18m
ARRYArray BioPharma Inc.
3.21%23.448.2%$111.48m
EXELExelixis, Inc.
0.71%21.376.4%$82.65m
NBIXNeurocrine Biosciences, Inc.
1.72%78.645.1%$78.55m

Company Profile

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.